Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis

被引:1
|
作者
Tintore, Mar [1 ]
机构
[1] Hosp Univ Vall Hebron, Dept Neurol Neuroimmunol, Ps Vall dHebron,119-129, Barcelona 08035, Spain
关键词
multiple sclerosis; review; Sativex; spasticity; symptom management;
D O I
10.2217/nmt.15.56
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spasticity is a prevalent and troublesome symptom for people with multiple sclerosis (MS). Common instruments to measure MS spasticity include the clinician-rated (modified) Ashworth scale and the patient-rated 0-10 spasticity Numerical Rating Scale (NRS). Current opinion is that measurement of MS spasticity should incorporate the patient's perspective. Other instruments to assess spasticity-associated symptoms such as the Penn spasms frequency scale, sleep quality NRS and pain NRS can assist in tracking MS spasticity evolution and inform management choices. Worsening spasticity reduces patient autonomy, impacts negatively on quality of life and increases health resource utilization and costs. Despite the wide range of issues associated with MS spasticity, undertreatment is common and standard treatment options (physiotherapy and classical oral therapies) often fail to provide adequate symptomatic control.
引用
收藏
页码:15 / 17
页数:3
相关论文
共 50 条
  • [31] NEW ADVANCES IN SYMPTOM MANAGEMENT IN MULTIPLE-SCLEROSIS
    SCHAPIRO, RT
    CLINICAL NEUROSCIENCE, 1994, 2 (3-4) : 266 - 270
  • [32] Multiple Sclerosis, Neuromyelitis Optica and Spasticity: Control of Specific Symptoms and Quality of Life
    Patejdl, R.
    Tesar, S.
    Zettl, U. K.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2014, 82 (07) : 373 - 385
  • [33] New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
    Smith, Paul F.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 : 59 - 63
  • [35] Therapeutic Advances in Multiple Sclerosis
    Yang, Jennifer H.
    Rempe, Torge
    Whitmire, Natalie
    Dunn-Pirio, Anastasie
    Graves, Jennifer S.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [36] Multiple Sklerose und SpastikMultiple Sclerosis and Spasticity
    Birgit Meister
    Akupunktur & Aurikulomedizin, 2021, 47 (4) : 36 - 38
  • [37] Consensus document on spasticity in patients with multiple sclerosis
    Oreja-Guevara, Celia
    Montalban, Xavier
    de Andres, Clara
    Casanova-Estruch, Bonaventura
    Munoz-Garcia, Delicias
    Garcia, Inmaculada
    Fernandez, Oscar
    REVISTA DE NEUROLOGIA, 2013, 57 (08) : 359 - 373
  • [38] Italian consensus on treatment of spasticity in multiple sclerosis
    Comi, G.
    Solari, A.
    Leocani, L.
    Centonze, D.
    Otero-Romero, S.
    Amadeo, Roberta
    Amato, Maria Pia
    Bertolotto, Antonio
    Boffa, Laura
    Brichetto, Giampaolo
    Centonze, Diego
    Comi, Giancarlo
    Comola, Mauro
    Ghezzi, Angelo
    Leocani, Letizia
    Lus, Giacomo
    Marrosu, Maria Giovanna
    Molteni, Franco
    Otero-Romero, Susana
    Patti, Francesco
    Pozzilli, Carlo
    Rovaris, Marco
    Sacca, Francesco
    Sessa, Edoardo
    Solari, Alessandra
    Solaro, Claudio
    Trojano, Maria
    Trompetto, Carlo
    Zaffaroni, Mauro
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (03) : 445 - 453
  • [39] Therapeutics for Multiple Sclerosis Symptoms
    Ben-Zacharia, Aliza Bitton
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 176 - 191
  • [40] Spasticity in multiple sclerosis: results of a patient survey
    Oreja-Guevara, C.
    Gonzalez-Segura, D.
    Vila, C.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (06) : 400 - 408